MAPT and Alzheimer disease: Compared with AD, the sensitivity and specificity of lower CSF p-tau concentrations in distinguishing iNPH were 0.943 (95% CI 0.871–0.981) and 0.851 (95% CI 0.767–0.914), respectively.